Antidepressants During Pregnancy Tied to Greater Risk of Gestational Diabetes
Taking antidepressants during pregnancy is linked to a greater risk of developing gestational diabetes, according to a new Canadian study published in the online journal BMJ Open.
Gestational diabetes is a type of diabetes that develops during pregnancy. It affects one in 5 pregnant women worldwide. Like other types of diabetes, gestational diabetes affects how your cells use sugar (glucose).
These pregnancies are prone to complications, such as overweight babies and prolonged labor due to the baby getting stuck in the birth canal. The children of these pregnancies may also be more vulnerable to obesity and diabetes later on, while the moms are more likely to develop type 2 diabetes and cardiovascular disease.
The researchers found that risk was highest among women who were taking venlafaxine, a serotonin and norepinephrine reuptake inhibitor (SNRI) that goes by the brand name Effexor, and amitriptyline (Elavil), which belongs to an older class of antidepressant, known as tricyclics.
For the study, the researchers drew on information from the Quebec Pregnancy Cohort, which incorporates three Canadian databases, and includes all pregnancies and children born in Quebec between 1998 and 2015.
Each case of gestational diabetes (20,905), identified after 20 weeks of pregnancy, was randomly matched with 10 unaffected pregnancies (209,050) of the same age and calendar year of delivery.
Antidepressant use was assessed using information on prescriptions filled for these drugs between the start of pregnancy and the diagnosis of gestational diabetes. In all, 9,741 (just over 4%) of the moms took antidepressants, singly or combined.
These included citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline, all of which are selective serotonin reuptake inhibitors, or SSRIs for short; venlafaxine; and amitriptyline.
After taking into account potentially influential factors, such as the mom’s age, welfare assistance, area of residence and other underlying conditions, the researchers found that taking antidepressants during pregnancy was linked to a heightened risk of developing gestational diabetes.
Taking any of these drugs was associated with a 19% heightened risk of being diagnosed with the condition compared with not taking antidepressants during pregnancy.
The risk was greatest for two antidepressant drugs, in particular: venlafaxine (27% heightened risk); and amitriptyline (52% heightened risk). What’s more, the risk increased, the longer certain types of antidepressants were taken, specifically SNRIs and tricyclics, singly or when combined.
Short term use was linked to a 15% greater risk; medium term use was associated with a 17% greater risk; and long term use with a 29% greater risk.
When further analysis was done on a smaller group of women (21,395) who had been diagnosed with depression/anxiety before they became pregnant, the findings were similar to those of the main analysis.
This is an observational study, and as such, doesn’t establish cause. But there are some possible explanations for what they found, say the researchers.
This includes that antidepressants directly affect glucose metabolism, especially as serotonin is involved in this process. And one of the side effects of antidepressants is weight gain, a risk factor for diabetes.
But the pros and cons of taking antidepressants during pregnancy need to be weighed carefully, warn the researchers, particularly for women whose depression is severe.
“The treatment of depression is a major concern and is challenging because depression is prevalent before and during pregnancy, and untreated depression can lead to relapse during pregnancy and in the [period immediately after birth],” they write.
Pedersen, T. (2019). Antidepressants During Pregnancy Tied to Greater Risk of Gestational Diabetes. Psych Central. Retrieved on July 11, 2020, from https://psychcentral.com/news/2019/10/14/antidepressants-during-pregnancy-tied-to-greater-risk-of-gestational-diabetes/151017.html